Waraporn Denjalearn, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Stanford Health Care · Ascension Medical Group Promed · Utmb Faculty Group Practice
Looking this up.
Hospitals listed: University of Texas Medical Branch. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Waraporn Denjalearn’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- University of Texas Medical Branch GalvestonGalveston, TXAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of The University of Texas System, which runs 7 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.231, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.48, Oct 2024 – Sep 2025
See every measure and the patient survey for University of Texas Medical Branch Galveston
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.48 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.49 (0.6 to 2.38) · 1,573 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.83 to 1.35) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 170.64 (131.24 to 210.03) · 120 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.1 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 174 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 239 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 699 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 632 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 5,418 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.11 to 0.48) · 9,148 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.08 to 0.45) · 9,326 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.23 (1.38 to 5.08) · 2,104 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0.08 to 3.03) · 539 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.35 to 3.96) · 1,933 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.09 (3.52 to 14.65) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.77 (3.54 to 10.01) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.44 (0.06 to 2.83) · 534 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.75 (0.24 to 1.26) · 7,932 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.675 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.994 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 459 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,442 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 25 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11 · 798 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 661 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 1,177 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (3.8 to 9) · 90 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (8 to 15.6) · 90 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.5 · 141 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.8 · 433 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.9 to 16.3) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 693 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,536 patients answered, 12% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$5,506
Medicare paid this office $5,506 for 48 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 12 | $1,376 | $98 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 1-10 | None |
Who their Medicare patients are
48 Original Medicare patients in 2024. Average age 72 · Women 48% · Health risk score 1.00. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 73% · Coronary heart disease 42% · Heart failure 42% · Chronic kidney disease 33% · Diabetes 25% · Depression 25% · COPD 23%.
The office billed $26,726, Medicare allowed $6,963 and paid $5,506; for 77 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 48 | 77 | 72 | 1.00 | $26,726 | $5,506 |
| 2023 | 11 | 24 | 70 | 0.81 | $6,389 | $1,252 |
| 2019 | 82 | 152 | 76 | 3.05 | $57,562 | $17,278 |
| 2018 | 96 | 168 | 72 | 3.40 | $185,585 | $19,555 |
| 2017 | 15 | 21 | 77 | 1.55 | $24,786 | $2,626 |
| 2016 | 15 | 84 | 68 | 5.33 | $37,347 | $9,124 |
| 2015 | 91 | 224 | 71 | 3.09 | $133,129 | $32,484 |
| 2014 | 87 | 300 | 71 | 2.88 | $152,138 | $37,791 |
| 2013 | 27 | 108 | 71 | 2.95 | $48,555 | $11,898 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 2 services
| Critical care, first 30-74 minutes | 56 | $12,718 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $2,825 | $74 |
2018: 3 services
| Critical care, first 30-74 minutes | 37 | $10,328 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $5,784 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,165 | $155 |
2016: 2 services
| Critical care, first 30-74 minutes | 15 | $5,774 | $148 |
| Critical care, each additional 30 minutes | 11 | $2,992 | $77 |
2015: 1 service
| Critical care, first 30-74 minutes | 90 | $32,022 | $150 |
2014: 2 services
| Critical care, first 30-74 minutes | 82 | $29,837 | $152 |
| Critical care, each additional 30 minutes | 33 | $7,314 | $76 |
2013: 2 services
| Critical care, first 30-74 minutes | 24 | $8,104 | $145 |
| Critical care, each additional 30 minutes | 18 | $3,400 | $74 |
Drugs they prescribed that Part D paid
$11,436
Pharmacies billed $11,436 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
232 generic and fewer than 11 brand-name prescriptions · $11,436 in drug cost · 49 antibiotic prescriptions to 42 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Triamcinolone Acetonide | 11 | $141 | $13 |
| Amlodipine Besylate | 11 | $44 | $4 |
| Clopidogrel | 13 | $30 | $2 |
| Prednisone | 11 | $18 | $2 |
Year by year
| 2024 | 254 | 103 | None | None | $11,436 |
| 2023 | 745 | 294 | 4% (31) | None | $25,290 |
| 2022 | 450 | 127 | 11% (48) | None | $24,234 |
| 2021 | 128 | 64 | 0% (0) | 12% | $1,828 |
| 2020 | 46 | 18 | None | None | $2,430 |
| 2019 | 27 | 12 | None | None | $2,077 |
| 2018 | 43 | 25 | None | None | $1,781 |
| 2017 | 112 | 30 | None | None | $5,690 |
| 2014 | 2,085 | 116 | 4% (73) | 21% | $96,429 |
| 2013 | 6,042 | 172 | 3% (184) | 22% | $255,324 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Neomycin-Polymyxin-Hc | 24 | $1,738 | $72 |
| Albuterol Sulfate Hfa | 20 | $832 | $42 |
| Valacyclovir | 11 | $698 | $63 |
| Triamcinolone Acetonide | 27 | $605 | $22 |
| Clopidogrel | 31 | $600 | $19 |
| Atorvastatin | 20 | $430 | $21 |
| Mupirocin | 30 | $400 | $13 |
| Azithromycin | 56 | $342 | $6 |
| Metoprolol | 25 | $335 | $13 |
| Erythromycin | 14 | $236 | $17 |
| Tamsulosin | 13 | $232 | $18 |
| Amoxicillin-Clavulanate Potass | 19 | $222 | $12 |
| Cephalexin | 20 | $165 | $8 |
| Methylprednisolone | 13 | $136 | $10 |
| Hydrocodone-Acetaminophen | 15 | $133 | $9 |
| Sulfamethoxazole-Trimethoprim | 21 | $122 | $6 |
| Cyclobenzaprine | 21 | $112 | $5 |
| Pantoprazole | 11 | $111 | $10 |
| Levofloxacin | 13 | $110 | $8 |
| Amoxicillin | 14 | $96 | $7 |
| Prednisone | 29 | $88 | $3 |
| Ibuprofen | 11 | $60 | $5 |
2022: 9 drugs
| Albuterol Sulfate Hfa | 11 | $465 | $42 |
| Atorvastatin | 21 | $461 | $22 |
| Hydrocodone-Acetaminophen | 24 | $401 | $17 |
| Clopidogrel | 22 | $382 | $17 |
| Pantoprazole | 13 | $275 | $21 |
| Tamsulosin | 25 | $264 | $11 |
| Metoprolol | 12 | $163 | $14 |
| Lisinopril | 15 | $101 | $7 |
| Tramadol | 11 | $19 | $2 |
2021: 1 drug
| Cephalexin | 15 | $79 | $5 |
2017: 1 drug
| Omeprazole | 11 | $52 | $5 |
2014: 49 drugs
| Diovan | 37 | $7,766 | $210 |
| Lantus | 25 | $6,454 | $258 |
| Nexium | 22 | $5,328 | $242 |
| Januvia | 17 | $4,695 | $276 |
| Crestor | 25 | $4,670 | $187 |
| Janumet | 17 | $4,358 | $256 |
| Onglyza | 15 | $4,259 | $284 |
| Exforge | 16 | $3,012 | $188 |
| Niacin Er | 16 | $2,317 | $145 |
| Avodart | 12 | $1,696 | $141 |
| Voltaren | 38 | $1,667 | $44 |
| Metoprolol | 46 | $1,079 | $23 |
| Omeprazole | 114 | $863 | $8 |
| Levothyroxine | 78 | $831 | $11 |
| Atorvastatin | 63 | $652 | $10 |
| Proair Hfa | 13 | $651 | $50 |
| Tamsulosin | 37 | $576 | $16 |
| Clopidogrel | 37 | $515 | $14 |
| Amlodipine Besylate | 109 | $467 | $4 |
| Pravastatin | 21 | $419 | $20 |
| Gabapentin | 43 | $405 | $9 |
| Metformin | 79 | $400 | $5 |
| Hydralazine | 28 | $365 | $13 |
| Tramadol | 73 | $329 | $5 |
| Nifedical Xl | 14 | $318 | $23 |
| Lactulose | 30 | $249 | $8 |
| Glyburide | 18 | $246 | $14 |
| Gemfibrozil | 22 | $243 | $11 |
| Valsartan-Hydrochlorothiazide | 11 | $237 | $22 |
| Enalapril Maleate | 36 | $234 | $7 |
| Meclizine | 16 | $227 | $14 |
| Simvastatin | 52 | $226 | $4 |
| Losartan | 28 | $204 | $7 |
| Glimepiride | 38 | $201 | $5 |
| Finasteride | 14 | $200 | $14 |
| Clonidine | 50 | $194 | $4 |
| Lisinopril | 46 | $181 | $4 |
| Losartan-Hydrochlorothiazide | 18 | $174 | $10 |
| Carvedilol | 23 | $172 | $7 |
| Azithromycin | 19 | $142 | $7 |
| Naproxen | 23 | $131 | $6 |
| Alendronate | 21 | $119 | $6 |
| Propranolol | 31 | $108 | $3 |
| Ibuprofen | 17 | $104 | $6 |
| Furosemide | 27 | $92 | $3 |
| Hydrochlorothiazide | 13 | $75 | $6 |
| Metoprolol | 19 | $69 | $4 |
| Cephalexin | 12 | $66 | $6 |
| Amitriptyline | 12 | $49 | $4 |
2013: 102 drugs
| Januvia | 62 | $15,807 | $255 |
| Nexium | 69 | $14,550 | $211 |
| Onglyza | 54 | $13,606 | $252 |
| Crestor | 69 | $11,677 | $169 |
| Lantus | 46 | $11,221 | $244 |
| Diovan | 79 | $10,808 | $137 |
| Lidoderm | 37 | $10,469 | $283 |
| Exforge | 44 | $7,061 | $160 |
| Janumet | 28 | $5,901 | $211 |
| Niaspan | 37 | $5,402 | $146 |
| Avodart | 37 | $4,828 | $130 |
| Clopidogrel | 91 | $4,461 | $49 |
| Atorvastatin | 220 | $4,273 | $19 |
| Victoza 2-Pak | 12 | $4,042 | $337 |
| Voltaren | 96 | $3,730 | $39 |
| Tradjenta | 14 | $3,505 | $250 |
| Metoprolol | 135 | $3,329 | $25 |
| Omeprazole | 353 | $3,309 | $9 |
| Advair Diskus | 13 | $3,243 | $249 |
| Fenofibrate | 28 | $2,858 | $102 |
| Aggrenox | 12 | $2,820 | $235 |
| Namenda | 16 | $2,759 | $172 |
| Pioglitazone | 28 | $2,417 | $86 |
| Celebrex | 14 | $2,306 | $165 |
| Nasonex | 14 | $1,996 | $143 |
| Trilipix | 12 | $1,939 | $162 |
| Zetia | 11 | $1,793 | $163 |
| Niacin Er | 14 | $1,631 | $116 |
| Amlodipine Besylate | 288 | $1,532 | $5 |
| Levothyroxine | 202 | $1,522 | $8 |
| Tamsulosin | 108 | $1,494 | $14 |
| Glyburide | 99 | $1,389 | $14 |
| Evista | 11 | $1,368 | $124 |
| Metformin | 227 | $1,344 | $6 |
| Nifedical Xl | 49 | $1,160 | $24 |
| Fenofibrate | 19 | $1,101 | $58 |
| Lactulose | 76 | $976 | $13 |
| Simvastatin | 153 | $930 | $6 |
| Tramadol | 183 | $928 | $5 |
| Valsartan-Hydrochlorothiazide | 14 | $869 | $62 |
| Ropinirole | 23 | $853 | $37 |
| Lisinopril | 168 | $819 | $5 |
| Proair Hfa | 17 | $798 | $47 |
| Carvedilol | 80 | $797 | $10 |
| Glimepiride | 117 | $756 | $6 |
| Sucralfate | 20 | $750 | $37 |
| Gabapentin | 102 | $749 | $7 |
| Carbidopa-Levodopa Er | 12 | $690 | $58 |
| Easy Touch | 24 | $685 | $29 |
| Triamcinolone Acetonide | 26 | $668 | $26 |
| Meclizine | 54 | $651 | $12 |
| Pravastatin | 47 | $630 | $13 |
| Clonidine | 132 | $616 | $5 |
| Losartan | 47 | $615 | $13 |
| Naproxen | 106 | $609 | $6 |
| Gemfibrozil | 46 | $589 | $13 |
| Azithromycin | 64 | $581 | $9 |
| Alendronate | 75 | $580 | $8 |
| Losartan-Hydrochlorothiazide | 42 | $551 | $13 |
| Enalapril Maleate | 107 | $550 | $5 |
| Finasteride | 33 | $513 | $16 |
| Clotrimazole | 16 | $500 | $31 |
| Hydralazine | 40 | $473 | $12 |
| Quetiapine | 14 | $444 | $32 |
| Ultra Comfort | 26 | $432 | $17 |
| Montelukast | 23 | $398 | $17 |
| Furosemide | 102 | $397 | $4 |
| Ramipril | 19 | $376 | $20 |
| Digox | 35 | $366 | $10 |
| Neomycin-Polymyxin-Hydrocort | 15 | $311 | $21 |
| Fenofibrate | 17 | $302 | $18 |
| Hydroxyzine | 34 | $300 | $9 |
| Warfarin | 31 | $274 | $9 |
| Propylthiouracil | 24 | $263 | $11 |
| Propranolol | 58 | $239 | $4 |
| Ibuprofen | 55 | $233 | $4 |
| Metronidazole | 18 | $232 | $13 |
| Generlac | 19 | $218 | $11 |
| Cilostazol | 14 | $218 | $16 |
| Potassium Chloride | 16 | $208 | $13 |
| Nitrostat | 15 | $207 | $14 |
| Dicyclomine | 35 | $184 | $5 |
| Hydrochlorothiazide | 31 | $172 | $6 |
| Topiramate | 15 | $169 | $11 |
| Cephalexin | 20 | $168 | $8 |
| Donepezil | 16 | $167 | $10 |
| Triamterene-Hctz | 20 | $160 | $8 |
| Paroxetine | 20 | $153 | $8 |
| Lisinopril-Hydrochlorothiazide | 21 | $153 | $7 |
| Pantoprazole | 12 | $149 | $12 |
| Amiodarone | 13 | $132 | $10 |
| Famotidine | 26 | $128 | $5 |
| Benazepril | 11 | $126 | $11 |
| Spironolactone | 12 | $122 | $10 |
| Metoprolol | 32 | $121 | $4 |
| Atenolol | 33 | $117 | $4 |
| Chlorthalidone | 15 | $85 | $6 |
| Amitriptyline | 19 | $79 | $4 |
| Fluoxetine | 12 | $76 | $6 |
| Amoxicillin | 16 | $74 | $5 |
| Prednisone | 24 | $69 | $3 |
| Baclofen | 11 | $51 | $5 |
Money from drug and device companies
$565 in 2025
| 2025 | 2 | 4 | None | $565 |
| 2024 | 1 | 1 | None | $8 |
| 2022 | 2 | 2 | None | $119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Getinge USA Sales | Vasoview Hemopro 2 | $558 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $7 | 1 payment
|
See all 4 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-26 | Lifevest | $7 |
| Getinge USA Sales | Travel · 2025-10-10 | Vasoview Hemopro 2 | $501 |
| Getinge USA Sales | Meals · 2025-08-13 | Vasoview Hemopro 2 | $27 |
| Getinge USA Sales | Meals · 2025-08-11 | Vasoview Hemopro 2 | $30 |
See earlier years (2024, 2022)
2024: $8
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $8 | 1 payment
|
2022: $119
| Getinge USA Sales | Vasoview Hemopro 2 | $101 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $18 | 1 payment
|
Professional record
- NPI
- 1669760310
- Licence
- CA NP21483, IN 71007132A, WV 117578
- Group
- Stanford Health Care · Ascension Medical Group Promed · Utmb Faculty Group Practice
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- IN 300055568
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 363LF0000X (363LF0000X); Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-07-15
- NPI last updated
- 2026-06-02
- NPI record certified
- 2026-06-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2651 E Discovery Pkwy, Bloomington, IN, 47408 · 707 W 2nd St, Bloomington, IN, 47403 · 3100 Maccorkle Ave Se Ste 101, Charleston, WV, 25304 · 2823 Fresno St, Fresno, CA, 93721 · 225 N Jackson Ave, San Jose, CA, 95116 · 1959 Ne Pacific St, Seattle, WA, 98195
This office lists an electronic records connection.